BioLamina

About:

BioLamina is a biotechnology company with a global presence, offering cell culture matrices for primary cells.

Website: http://www.biolamina.com/

Twitter/X: biolamina

Top Investors: Lauxera Capital Partners, Bure Equity AB, Northislet

Description:

Total Funding Amount:

17M EUR

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Sundbyberg, Stockholms Lan, Sweden

Founded Date:

2008-01-01

Contact Email:

info(AT)biolamina.com

Founders:

Kristian Tryggvason

Number of Employees:

51-100

Last Funding Date:

2023-09-12

IPO Status:

Private

Industries: